Publication | Closed Access
Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study
45
Citations
25
References
2015
Year
Hematological MalignancyLymphoid NeoplasiaOpen-label Phase 1B/2MedicineImmunologyPathologyImmune Checkpoint InhibitorImmunotherapyOncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1